数位病理学市场规模、份额、成长分析（按产品、类型、应用、最终用途和地区）- 2025-2032 年产业预测

全球数位病理检测市场规模预计在 2023 年达到 9 亿美元，到 2032 年将达到 17.7 亿美元，预计在预测期内（2025-2032 年）的复合年增长率为 7.8%。

由于癌症和心血管疾病发病率的不断上升，需要精确的诊断工具，数位病理学市场正在经历显着增长。慢性病的增加推动了对该领域主要企业开发的先进数位病理学检测系统的需求。 Medscape 称，死亡率的上升与这些疾病有关，为进一步创新提供了动力。数位病理学透过组织宏观影像和实施影像分析方法来增强调查流程。此外，对远端病理学解决方案进行远端评估和即时咨询的依赖日益增加以及政府资助是推动市场扩张的主要因素。随着这些技术的发展，它们将促进诊断的改进并创造更有效率的医疗保健环境。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析

数位病理学测试市场规模（按产品和复合年增长率）（2025-2032）

• 市场概览
• 扫描器
  • 明场扫描仪
  • 萤光扫描仪
  • 其他扫描仪
• 软体
  • 整合软体
  • StandOne软体
• 部署模型
  • 云端基础模式
  • 本地模型
  • 混合模式
• 储存系统

数位病理学测试市场规模（按类型和复合年增长率）（2025-2032）

• 市场概览
• 人体病理学
• 兽医病理学

数位病理学测试市场规模（按应用和复合年增长率）（2025-2032）

• 市场概览
• 药物研发
• 学术研究
• 疾病诊断
  • 癌细胞检测
  • 其他的

数位病理学检测市场规模（按最终用途和复合年增长率） (2025-2032)

• 市场概览
• 医院
• 生物技术和製药公司
• 诊断实验室
• 学术研究所

数位病理学测试市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较比较（2022-2024 年）

主要企业简介

• Koninklijke Philips NV（Netherlands）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Hamamatsu Photonics KK（Japan）
• Olympus Corporation（Japan）
• PerkinElmer, Inc.（United States）
• 3DHISTECH Ltd.（Hungary）
• Sectra AB（Sweden）
• Visiopharm A/S（Denmark）
• Apollo Enterprise Imaging Corporation（Canada）
• Corista LLC（United States）
• Paige.AI, Inc.（United States）
• Ibex Medical Analytics Ltd.（Israel）
• Indica Labs, Inc.（United States）
• Proscia Inc.（United States）
• Deep Lens Inc.（United States）
• Aiforia Technologies Oyj（Finland）
• OptraSCAN, Inc.（United States）
• Mikroscan Technologies, Inc.（United States）
• Xilis, Inc.（United States）

结论和建议

Global Digital Pathology Market size was valued at USD 0.9 billion in 2023 and is poised to grow from USD 0.97 billion in 2024 to USD 1.77 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The digital pathology market is experiencing significant growth due to the increasing incidence of cancer and cardiovascular diseases, necessitating precise diagnostic tools. The rise in chronic illnesses has heightened the demand for advanced digital pathology systems developed by major players in the field. According to Medscape, an uptick in mortality rates correlates with these conditions, driving further innovation. Digital pathology enhances research pipelines by organizing macroscopic images and implementing image analysis methods. Additionally, government funding, along with the growing reliance on telepathology solutions for remote evaluations and real-time consultations, are key factors propelling market expansion. As these technologies evolve, they facilitate enhanced diagnostics, fostering a more efficient healthcare landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Digital Pathology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Digital Pathology Market Segments Analysis

Global Digital Pathology Market is segmented by Product, Type, Application, End-use and region. Based on Product, the market is segmented into Scanners, Software, Deployment Model and Storage System. Based on Type, the market is segmented into Human Pathology and Veterinary Pathology. Based on Application, the market is segmented into Drug Discovery & Development, Academic Research and Disease Diagnosis. Based on End-use, the market is segmented into Hospitals, Biotech & Pharma Companies, Diagnostic Labs and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Digital Pathology Market

The Global Digital Pathology market is significantly driven by technological advancements including whole-slide imaging (WSI), advanced image analysis tools, and the integration of artificial intelligence (AI). These innovations have revolutionized the field of digital pathology, making it more appealing to healthcare providers by enhancing diagnostic accuracy, boosting operational efficiency, and facilitating automated workflow processes. As a consequence of these developments, digital pathology is becoming an essential component in modern healthcare practices, leading to widespread adoption and contributing to the overall growth of the market. The continuous evolution of these technologies promises to further enhance the capabilities of digital pathology in the future.

Restraints in the Global Digital Pathology Market

The Global Digital Pathology market faces significant constraints due to the complex and labor-intensive nature of integrating existing healthcare IT infrastructures with digital pathology solutions. This challenge is particularly pronounced in institutions that rely on outdated technologies, where compatibility issues and the extensive modifications required can create obstacles to system adoption. These complications can hinder the smooth implementation and optimization of digital pathology workflows, ultimately impeding the overall acceptance of these advanced systems within healthcare organizations and limiting their effectiveness in improving diagnostic processes and patient outcomes.

Market Trends of the Global Digital Pathology Market

The global digital pathology market is witnessing a significant shift towards fully cloud-based solutions, driven by advancements in imaging technology and a growing emphasis on scalable, collaborative, and personalized healthcare. As the demand for eco-friendly diagnostic tools escalates, digital pathology is increasingly being recognized for its ability to facilitate efficient data collection, management, and analysis. The adoption of Whole Slide Imaging (WSI) is a standout trend, enabling pathologists to digitally access and analyze entire tissue slides, significantly improving diagnostic accuracy and workflow efficiency. This market evolution is indicative of a broader move towards innovative healthcare solutions that enhance collaboration and improve patient outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Digital Pathology Market Size by Product & CAGR (2025-2032)

• Market Overview
• Scanners
  • Brightfield Scanners
  • Fluorescence Scanners
  • Other Scanners
• Software
  • Integarted Software
  • Standone Software
• Deployment Model
  • Cloud-Based Model
  • On-Premise Model
  • Hybrid Model
• Storage System

Global Digital Pathology Market Size by Type & CAGR (2025-2032)

• Market Overview
• Human Pathology
• Veterinary Pathology

Global Digital Pathology Market Size by Application & CAGR (2025-2032)

• Market Overview
• Drug Discovery & Development
• Academic Research
• Disease Diagnosis
  • Cancer Cell Detection
  • Others

Global Digital Pathology Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Biotech & Pharma Companies
• Diagnostic Labs
• Academic & Research Institutes

Global Digital Pathology Market Size & CAGR (2025-2032)

• North America (Product, Type, Application, End-use)
  • US
  • Canada
• Europe (Product, Type, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Type, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Type, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Type, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hamamatsu Photonics K.K. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3DHISTECH Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sectra AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Visiopharm A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Apollo Enterprise Imaging Corporation (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corista LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Paige.AI, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ibex Medical Analytics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indica Labs, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Proscia Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Deep Lens Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aiforia Technologies Oyj (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptraSCAN, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mikroscan Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xilis, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations